Drug Trial Radar · NCT03611751
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Dec 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,020
Actual
Start
Jul 26, 2018
Primary completion
Nov 29, 2020
Study completion Nov 30, 2020
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Aug 2, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.
Conditions
- Psoriasis
Interventions
BMS-986165Drug
Specified dose on specified days
PlaceboOther
Specified dose on specified days
ApremilastDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Number of Participants With a Static Physician's Global Assessment (sPGA) Score of 0 or 1 in Participants Receiving BMS-986165 Compared to Placebo at Week 16 (sPGA 0/1)Time frame: Week 16
- The Number of Participants Who Achieve a 75% Improvement From Baseline in the Psoriasis Area and Severity Index (PASI) Score in Participants Receiving BMS-986165 Compared to Placebo at Week 16 (PASI 75)Time frame: Baseline and Week 16
Locations
205 sites in 16 countries. Site status is shown where the registry gives one.
Total Skin and Beauty Dermatology Center
Birmingham, Alabama
The Kirklin Clinic of UAB Hospital
Birmingham, Alabama
Alliance Dermatology and Mohs Center - Phoenix
Phoenix, Arizona
Clinical Research Consortium - Tempe
Tempe, Arizona
Johnson Dermatology
Fort Smith, Arkansas
Burke Pharmaceutical Research
Hot Springs, Arkansas
Applied Research Center of Arkansas
Little Rock, Arkansas
Anaheim Clinical Trials
Anaheim, California
Center for Dermatology Clinical Research
Fremont, California
Associates in Research, Inc.
Fresno, California
Marvel Clinical Research
Huntington Beach, California
Interspond - Long Beach Clinical Trials
Long Beach, California
Dermatology Research Associates - Los Angeles
Los Angeles, California
LA Universal Research Center
Los Angeles, California
Artemis Institute for Clinical Research - San Diego
San Diego, California
University of California San Diego Health Systems
San Diego, California
Therapeutics Clinical Research
San Diego, California
San Luis Dermatology and Laser Clinic
San Luis Obispo, California
Artemis Institute for Clinical Research - San Marcos
San Marcos, California
West Coast Research
San Ramon, California
Clinical Science Institute
Santa Monica, California
Synexus - Santa Rosa
Santa Rosa, California
Care Access Research - Walnut Creek
Walnut Creek, California
Stamford Therapeutics Consortium
Stamford, Connecticut
Skin Care Research
Boca Raton, Florida
ERN - Accel Research - Avail
DeLand, Florida
Interspond - Savin Medical Group
Miami Lakes, Florida
Synexus Clinical Research - Saint Petersburg
Pinellas Park, Florida
Progressive Medical Research
Port Orange, Florida
Precision Clinical Research - Corporate Office
Sunrise, Florida
Precision Clinical Research - Corporate Office
Tamarac, Florida
Moore Clinical Research - South Tampa
Tampa, Florida
University of South Florida/USF Health
Tampa, Florida
ForCare Clinical Research
Tampa, Florida
Marietta Dermatology & The Skin Cancer Center
Marietta, Georgia
Advanced Clinical Research - Idaho
Meridian, Idaho
Glazer Dermatology
Buffalo Grove, Illinois
Southern Illinois University School of Medicine
Springfield, Illinois
Dundee Dermatology
West Dundee, Illinois
Dermatology Center of Northwest Indiana
Crown Point, Indiana
Showing 40 of 205 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.